Keystone is our proprietary analytics platform for microbiome analysis with applications in areas such as clinical trial analysis and early disease prediction. Supported by a state-of-the-art cloud-based IT infrastructure, Keystone is able to operate in any region globally and process high throughput data analysis. We employ a range of innovative statistical bioinformatics methodology, machine learning and data visualization tools for large-scale data analysis and interpretation. Keystone brings quality, precision, and new insights to drug development.

Some Keystone analytic outputs include: